Ravindranaths M H, Paulson J C, Irie R F
Division of Surgical Oncology, Jonsson Comprehensive Cancer Center, UCLA School of Medicine 90024.
J Biol Chem. 1988 Feb 5;263(4):2079-86.
A lectin that can specifically bind to O-acetylsialic acids, found in glycoproteins and gangliosides, was purified to homogeneity from a crab Cancer antennarius (crab lectin) (Ravindranath, M. H., Higa, H. H., Cooper, E. L., and Paulson, J. C. (1985) J. Biol. Chem. 260, 8850-8856; Correction (1986) J. Biol. Chem. 261, 1983; Ravindranath, M. H., and Paulson, J. C. (1987) Methods Enzymol. 138, 520-527). We tested lectin binding to human melanoma cell lines to identify O-acetylsialylated gangliosides on the melanoma cell surface. The highest degree of binding of the crab lectin was demonstrated on a melanoma cell line, UCLASO-M25. To confirm that the binding was due to O-acetylsialic acid in the alkali-labile gangliosides, the gangliosides were isolated and purified from M25 cells and individually coated onto sheep asialoerythrocytes, which served as targets in an agglutination assay using the lectin. The crab lectin agglutinated the asialo-sheep erythrocytes coated with alkali-labile gangliosides, but the lectin failed to agglutinate the asialoerythrocytes coated with GM3, GD3, and base-treated gangliosides. Subsequently, the purified alkali-labile M25 ganglioside was base-treated and applied to TLC, and we found that it was converted to a slower migrating species identical to the disialolactosylceramide (GD3). These results indicate that O-acetyl GD3 expressed on the melanoma cell surface is recognized by the lectin. Because O-acetyl GD3 is not expressed on human normal tissues, we examined the capability of O-acetyl GD3 to induce immune responses in man. Sera from patients with melanoma were tested against M25 cells in an immuneadherence assay, and those positive to the M25 cell line were further tested for specificity to O-acetyl gangliosides. The presence of autoantibodies to O-acetyl-GD3 in melanoma sera was confirmed by blocking of the antigen sites on M25 cells by the lectin or preabsorption of the sera with erythrocytes bearing O-acetyl gangliosides. The data provide evidence that O-acetyl-GD3 may represent an important tumor marker for detection and treatment of human melanoma.
从一种蟹(Cancer antennarius)中纯化得到了一种能特异性结合存在于糖蛋白和神经节苷脂中的O-乙酰神经氨酸的凝集素(蟹凝集素),并将其纯化至同质状态(拉温德拉纳特,M. H.,希加,H. H.,库珀,E. L.,和保尔森,J. C.(1985年)《生物化学杂志》260卷,8850 - 8856页;勘误(1986年)《生物化学杂志》261卷,1983页;拉温德拉纳特,M. H.,和保尔森,J. C.(1987年)《酶学方法》138卷,520 - 527页)。我们测试了凝集素与人黑色素瘤细胞系的结合情况,以鉴定黑色素瘤细胞表面的O-乙酰化神经节苷脂。蟹凝集素在一种黑色素瘤细胞系UCLASO-M25上表现出最高程度的结合。为了证实这种结合是由于碱不稳定神经节苷脂中的O-乙酰神经氨酸所致,从M25细胞中分离并纯化了神经节苷脂,然后将其分别包被在羊去唾液酸红细胞上,在使用该凝集素的凝集试验中,羊去唾液酸红细胞作为靶细胞。蟹凝集素能凝集包被有碱不稳定神经节苷脂的去唾液酸羊红细胞,但不能凝集包被有GM3、GD3和经碱处理的神经节苷脂的去唾液酸红细胞。随后,将纯化的碱不稳定M25神经节苷脂进行碱处理并应用于薄层层析,我们发现它转化为一种迁移速度较慢的物质,与二唾液酸乳糖基神经酰胺(GD3)相同。这些结果表明,黑色素瘤细胞表面表达的O-乙酰GD3可被该凝集素识别。由于O-乙酰GD3在人类正常组织中不表达,我们研究了O-乙酰GD3在人体内诱导免疫反应的能力。在免疫黏附试验中,检测了黑色素瘤患者血清对M25细胞的反应,对M25细胞系呈阳性反应的患者血清进一步检测其对O-乙酰神经节苷脂的特异性。通过凝集素封闭M25细胞上的抗原位点或用带有O-乙酰神经节苷脂的红细胞预先吸附血清,证实了黑色素瘤血清中存在针对O-乙酰-GD3的自身抗体。这些数据提供了证据,表明O-乙酰-GD3可能是检测和治疗人类黑色素瘤的一种重要肿瘤标志物。